• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄嘌呤脱氢酶/氧化酶的新突变导致严重的低尿酸血症:两例Ⅰ型黄嘌呤尿症捷克家系的生化和分子遗传学分析。

Novel mutations in xanthine dehydrogenase/oxidase cause severe hypouricemia: biochemical and molecular genetic analysis in two Czech families with xanthinuria type I.

机构信息

Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.

出版信息

Clin Chim Acta. 2012 Jan 18;413(1-2):93-9. doi: 10.1016/j.cca.2011.08.038. Epub 2011 Sep 22.

DOI:10.1016/j.cca.2011.08.038
PMID:21963464
Abstract

BACKGROUND

The article describes the clinical, biochemical, enzymological and molecular genetics findings in two patients from two families with xanthinuria type I.

METHODS

Biochemical analysis using high performance liquid chromatography, allopurinol loading test and analysis of xanthine oxidase activity in plasma and of uromodulin excretion in urine were performed. Sequencing analysis of the xanthine dehydrogenase gene and the haplotype and statistical analyses of consanguinity were performed.

RESULTS

Probands showed extremely low concentrations of uric acid, on seven occasions under the limit of detection. The concentration of uric acid in 38-year-old female was 15 μmol/L in serum and 0.04 mmol/L in urine. Excretion of xanthine in urine was 170 mmol/mol creatinine. The concentration of uric acid in 25-year-old male was 0.03 mmol/L in urine. Excretion of xanthine in urine was 141 mmol/mol creatinine. The allopurinol loading test confirmed xanthinuria type I. The xanthine oxidase activities in patients were 0 and 0.4 pmol/h/mL of plasma. We found three nonsense changes: p.P214QfsX4 and unpublished p.R825X and p.R881X.

CONCLUSIONS

We found two nonconsanguineous compound heterozygotes with xanthinuria type I caused by three nonsense changes. The methods used did not confirm consanguinity in the probands, thus there might be an unconfirmed biological relationship or mutational hotspot.

摘要

背景

本文描述了两例来自两个黄嘌呤尿症 I 型家族的患者的临床、生化、酶学和分子遗传学发现。

方法

采用高效液相色谱法、别嘌呤醇负荷试验及血浆黄嘌呤氧化酶活性和尿中尿调蛋白排泄分析进行生化分析。进行黄嘌呤脱氢酶基因的测序分析以及单倍型分析和近亲关系的统计分析。

结果

先证者血尿酸浓度极低,7 次检测均低于检测下限。38 岁女性血清尿酸浓度为 15 μmol/L,尿中尿酸浓度为 0.04 mmol/L。尿中黄嘌呤排泄量为 170 mmol/mol 肌酐。25 岁男性尿中尿酸浓度为 0.03 mmol/L。尿中黄嘌呤排泄量为 141 mmol/mol 肌酐。别嘌呤醇负荷试验证实为黄嘌呤尿症 I 型。患者的黄嘌呤氧化酶活性分别为 0 和 0.4 pmol/h/mL 血浆。我们发现了三个无义突变:p.P214QfsX4 和未发表的 p.R825X 和 p.R881X。

结论

我们发现了两例非近亲复合杂合子的黄嘌呤尿症 I 型,由三个无义突变引起。所采用的方法未确认先证者有近亲关系,因此可能存在未确认的生物学关系或突变热点。

相似文献

1
Novel mutations in xanthine dehydrogenase/oxidase cause severe hypouricemia: biochemical and molecular genetic analysis in two Czech families with xanthinuria type I.黄嘌呤脱氢酶/氧化酶的新突变导致严重的低尿酸血症:两例Ⅰ型黄嘌呤尿症捷克家系的生化和分子遗传学分析。
Clin Chim Acta. 2012 Jan 18;413(1-2):93-9. doi: 10.1016/j.cca.2011.08.038. Epub 2011 Sep 22.
2
Hereditary xanthinuria is not so rare disorder of purine metabolism.遗传性黄嘌呤尿症并非嘌呤代谢中罕见的病症。
Nucleosides Nucleotides Nucleic Acids. 2018;37(6):324-328. doi: 10.1080/15257770.2018.1460478. Epub 2018 May 3.
3
[A case of Xanthinuria in a patient with marked hypouricemia].[一例伴有显著低尿酸血症患者的黄嘌呤尿症]
G Ital Nefrol. 2011 Nov-Dec;28(6):648-53.
4
XDH gene mutation is the underlying cause of classical xanthinuria: a second report.XDH基因突变是典型黄嘌呤尿症的根本原因:第二篇报告
Kidney Int. 2000 Jun;57(6):2215-20. doi: 10.1046/j.1523-1755.2000.00082.x.
5
Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria.一个患有常染色体隐性经典黄嘌呤尿症的土耳其家族中黄嘌呤脱氢酶基因的突变分析。
Nephrol Dial Transplant. 2003 Nov;18(11):2278-83. doi: 10.1093/ndt/gfg385.
6
Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II).硫嘌呤诱导的毒性与人类钼辅因子硫代酶基因(黄嘌呤尿症 II 型)的功能异常变异有关。
Toxicol Appl Pharmacol. 2018 Aug 15;353:102-108. doi: 10.1016/j.taap.2018.06.015. Epub 2018 Jun 20.
7
[Xanthinuria type I as the cause of nephrolithiasis in 17-years old girl].[17岁女孩因I型黄嘌呤尿症导致肾结石]
Pol Merkur Lekarski. 2010 Aug;29(170):111-4.
8
Hereditary xanthinuria: report of two cases.遗传性黄嘌呤尿症:两例报告。
J Formos Med Assoc. 1993 May;92(5):478-81.
9
A novel mutation in xanthine dehydrogenase in a case with xanthinuria in Hunan province of China.中国湖南省一例黄嘌呤尿症患者中黄嘌呤脱氢酶的一种新突变。
Clin Chim Acta. 2020 May;504:168-171. doi: 10.1016/j.cca.2020.02.012. Epub 2020 Feb 15.
10
Identification of a xanthinuria type I case with mutations of xanthine dehydrogenase in an Afghan child.鉴定一名阿富汗儿童患黄嘌呤氧化酶缺乏症 I 型,其黄嘌呤脱氢酶存在突变。
Clin Chim Acta. 2012 Dec 24;414:158-60. doi: 10.1016/j.cca.2012.08.011. Epub 2012 Aug 17.

引用本文的文献

1
A prevalent MOCS2 variant in the Roma population is associated with a novel mild form of molybdenum cofactor deficiency.罗姆人群中一种常见的MOCS2变体与一种新型轻度钼辅因子缺乏症相关。
Eur J Pediatr. 2025 Jul 25;184(8):499. doi: 10.1007/s00431-025-06335-x.
2
Pseudogenization of the Slc23a4 gene is necessary for the survival of Xdh-deficient mice.Slc23a4基因的假基因化对于缺乏Xdh的小鼠的存活是必要的。
Sci Rep. 2025 Jan 25;15(1):3250. doi: 10.1038/s41598-025-87751-9.
3
Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular Disease.
基于药物遗传学对黄嘌呤脱氢酶在心血管疾病中进行治疗性开发的潜在机会。
Antioxidants (Basel). 2024 Nov 22;13(12):1439. doi: 10.3390/antiox13121439.
4
Xanthinuria in a familial group of Munchkin cats and an unrelated domestic shorthair cat.黄嘌呤尿症在一个芒奇金猫的家族群和一只不相关的家养短毛猫中。
J Feline Med Surg. 2024 May;26(5):1098612X241241408. doi: 10.1177/1098612X241241408.
5
Interleukin-37: associations of plasma levels and genetic variants in gout.白细胞介素-37:痛风患者血浆水平及基因变异的相关性。
Arthritis Res Ther. 2023 Oct 18;25(1):203. doi: 10.1186/s13075-023-03188-3.
6
Computational Characterization of the Inhibition Mechanism of Xanthine Oxidoreductase by Topiroxostat.托匹司他对黄嘌呤氧化还原酶抑制机制的计算表征
ACS Catal. 2023 May 5;13(9):6023-6043. doi: 10.1021/acscatal.3c01245. Epub 2023 Apr 18.
7
Investigation of the Inhibition Mechanism of Xanthine Oxidoreductase by Oxipurinol: A Computational Study.黄嘌呤氧化酶抑制剂别嘌呤醇抑制机制的研究:计算研究。
J Chem Inf Model. 2023 Jul 10;63(13):4190-4206. doi: 10.1021/acs.jcim.3c00624. Epub 2023 Jun 15.
8
Analysis of Purine Metabolism to Elucidate the Pathogenesis of Acute Kidney Injury in Renal Hypouricemia.通过嘌呤代谢分析以阐明肾性低尿酸血症中急性肾损伤的发病机制
Biomedicines. 2022 Jul 2;10(7):1584. doi: 10.3390/biomedicines10071584.
9
Functional Characterization of Rare Variants in OAT1/ and OAT3/ Urate Transporters Identified in a Gout and Hyperuricemia Cohort.在痛风和高尿酸血症队列中鉴定的 OAT1/和 OAT3/尿酸转运体中的罕见变异的功能特征。
Cells. 2022 Mar 22;11(7):1063. doi: 10.3390/cells11071063.
10
Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine Oxidoreductase.黄嘌呤尿症中鉴定出的突变与黄嘌呤氧化还原酶的功能及抑制机制的关联
Biomedicines. 2021 Nov 20;9(11):1723. doi: 10.3390/biomedicines9111723.